Registered Cardiovascular Invasive Specialist (RCIS) Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the Registered Cardiovascular Invasive Specialist Test with detailed quizzes, flashcards, and explanations for each question. Equip yourself for exam success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which of the following agents is not classified as an antiplatelet medication?

  1. Clopidogrel

  2. Warfarin

  3. Aspirin

  4. Heparin

The correct answer is: Heparin

The correct identification of an agent not classified as an antiplatelet medication lies in understanding the distinct functions of different classes of drugs used in cardiovascular care. Antiplatelet medications specifically inhibit platelet aggregation and are critical in preventing thrombus formation associated with cardiovascular events. Clopidogrel and aspirin are both well-established antiplatelet agents. Clopidogrel works by irreversibly inhibiting the P2Y12 ADP receptor on platelets, reducing their ability to aggregate. Similarly, aspirin inhibits cyclooxygenase-1 (COX-1), leading to a decrease in thromboxane A2 production, which is necessary for platelet activation and aggregation. Warfarin, on the other hand, is classified as an anticoagulant, which means it works by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver, thereby affecting the coagulation cascade rather than directly preventing platelet aggregation. Heparin is also an anticoagulant that enhances the activity of antithrombin III, which inhibits thrombin and factor Xa, preventing the formation of fibrin clots. Therefore, among the options provided, heparin is accurately identified as not being an antiplatelet medication, distinguishing it from agents like